Trails Edge Capital Partners, LP - Significant Ownership

Signature - Title
By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai - Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Location
Atlanta, GA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Trails Edge Capital Partners, LP.

Significant Ownership of Trails Edge Capital Partners, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MIST Milestone Pharmaceuticals Inc. Common Shares 9.9% $18M $340K 9.02M +1.92% Trails Edge Capital Partners, LP Sep 30, 2025
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.9% $9.08M 2.32M Trails Edge Capital Partners, LP Aug 11, 2025
VTVT vTv Therapeutics Inc. Common Stock, par value $0.01 per share 9.9% $5.11M 341K Trails Edge Capital Partners, LP Aug 29, 2025

Schedules 13D/G Reported by Trails Edge Capital Partners, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.